Neurog1-Derived Peptides RMNE1 and DualPep-Shine Penetrate the Skin and Inhibit Melanin Synthesis by Regulating MITF Transcription
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24076158 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ee Chan Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: Remedi Co., Ltd., Research Center, Incheon 21990, Republic of Korea. Hauptthemen laut MEDLINE: Melanins, Skin Pigmentation, Microphthalmia-Associated Transcription Factor, Transcription, Genetic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Small and Medium Business Administration, Starting growth Technological R&D Program.
Abstract (Originalsprache)
Anti-pigmentation peptides have been developed as alternative skin-lightening agents to replace conventional chemicals that have adverse effects on the skin. However, the maximum size of these peptides is often limited by their low skin and cell penetration. To address this issue, we used our intra-dermal delivery technology (IDDT) platform to identify peptides with hypo-pigmenting and high cell-penetrating activity. Using our cell-penetrating peptides (CPPs) from the IDDT platform, we identified RMNE1 and its derivative RMNE3, “DualPep-Shine”, which showed levels of α-Melanocyte stimulating hormone (α-MSH)-induced melanin inhibition comparable to the conventional tyrosinase inhibitor, Kojic acid. In addition, DualPep-Shine was delivered into the nucleus and regulated the gene expression levels of melanogenic enzymes by inhibiting the promoter activity of microphthalmia-associated transcription factor-M (MITF-M). Using a 3D human skin model, we found that DualPep-Shine penetrated the lower region of the epidermis and reduced the melanin content in a dose-dependent manner. Furthermore, DualPep-Shine showed high safety with little immunogenicity, indicating its potential as a novel cosmeceutical ingredient and anti-pigmentation therapeutic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Remedi Co., Ltd., Research Center, Incheon 21990, Republic of Korea.
- College of Pharmacy, Sahmyook University, Seoul 01795, Republic of Korea.
ORCID-Profile: Ee Chan Song, Sang Bum Kim, Seongmin Cho
Förderung
- Small and Medium Business Administration
- Starting growth Technological R&D Program
Zitieren
APA
Song, E. C., Park, C., Shin, Y., Kim, W. K., Kim, S. B., & Cho, S. (2023). Neurog1-Derived Peptides RMNE1 and DualPep-Shine Penetrate the Skin and Inhibit Melanin Synthesis by Regulating MITF Transcription. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076158
Vancouver
Song EC, Park C, Shin Y, Kim WK, Kim SB, Cho S. Neurog1-Derived Peptides RMNE1 and DualPep-Shine Penetrate the Skin and Inhibit Melanin Synthesis by Regulating MITF Transcription. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076158
BibTeX
@article{Song2023,
author = {Song, Ee Chan and Park, Chanho and Shin, Yungyeong and Kim, Wan Ki and Kim, Sang Bum and Cho, Seongmin},
title = {Neurog1-Derived Peptides RMNE1 and DualPep-Shine Penetrate the Skin and Inhibit Melanin Synthesis by Regulating MITF Transcription},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24076158}
}
EUVIMED